These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16310773)

  • 21. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
    Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
    Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slowed progression in models of Huntington disease by adipose stem cell transplantation.
    Lee ST; Chu K; Jung KH; Im WS; Park JE; Lim HC; Won CH; Shin SH; Lee SK; Kim M; Roh JK
    Ann Neurol; 2009 Nov; 66(5):671-81. PubMed ID: 19938161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal characterization of cognitive and motor deficits in an excitotoxic lesion model of striatal dysfunction in non-human primates.
    Lavisse S; Williams S; Lecourtois S; van Camp N; Guillermier M; Gipchtein P; Jan C; Goutal S; Eymin L; Valette J; Delzescaux T; Perrier AL; Hantraye P; Aron Badin R
    Neurobiol Dis; 2019 Oct; 130():104484. PubMed ID: 31132407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preservation of striatal tissue and behavioral function after neural stem cell transplantation in a rat model of Huntington's disease.
    Roberts TJ; Price J; Williams SC; Modo M
    Neuroscience; 2006; 139(4):1187-99. PubMed ID: 16517087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Embryonic donor age and dissection influences striatal graft development and functional integration in a rodent model of Huntington's disease.
    Watts C; Brasted PJ; Dunnett SB
    Exp Neurol; 2000 May; 163(1):85-97. PubMed ID: 10785447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease.
    Ebert AD; Barber AE; Heins BM; Svendsen CN
    Exp Neurol; 2010 Jul; 224(1):155-62. PubMed ID: 20227407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human neural stem cells improve sensorimotor deficits in the adult rat brain with experimental focal ischemia.
    Chu K; Kim M; Park KI; Jeong SW; Park HK; Jung KH; Lee ST; Kang L; Lee K; Park DK; Kim SU; Roh JK
    Brain Res; 2004 Aug; 1016(2):145-53. PubMed ID: 15246850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection by encapsulated choroid plexus in a rodent model of Huntington's disease.
    Borlongan CV; Skinner SJ; Geaney M; Vasconcellos AV; Elliott RB; Emerich DF
    Neuroreport; 2004 Nov; 15(16):2521-5. PubMed ID: 15538187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal firing activity and gene expression changes in the subthalamic nucleus after transplantation of dopamine neurons in hemiparkinsonian rats.
    Rumpel R; Alam M; Klein A; Özer M; Wesemann M; Jin X; Krauss JK; Schwabe K; Ratzka A; Grothe C
    Neurobiol Dis; 2013 Nov; 59():230-43. PubMed ID: 23938762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ketamine anaesthesia interferes with the quinolinic acid-induced lesion in a rat model of Huntington's disease.
    Jiang W; Büchele F; Papazoglou A; Döbrössy M; Nikkhah G
    J Neurosci Methods; 2009 May; 179(2):219-23. PubMed ID: 19428530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Xenotransplantation of human adipose derived mesenchymal stem cells in a rodent model of Huntington's disease: motor and non-motor outcomes.
    Hosseini M; Moghadas M; Edalatmanesh MA; Hashemzadeh MR
    Neurol Res; 2015 Apr; 37(4):309-19. PubMed ID: 25376132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant self-grooming as early marker of motor dysfunction in a rat model of Huntington's disease.
    Tartaglione AM; Armida M; Potenza RL; Pezzola A; Popoli P; Calamandrei G
    Behav Brain Res; 2016 Oct; 313():53-57. PubMed ID: 27374158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stem cells induced to secrete neurotrophic factors attenuate quinolinic acid toxicity: a potential therapy for Huntington's disease.
    Sadan O; Shemesh N; Barzilay R; Dadon-Nahum M; Blumenfeld-Katzir T; Assaf Y; Yeshurun M; Djaldetti R; Cohen Y; Melamed E; Offen D
    Exp Neurol; 2012 Apr; 234(2):417-27. PubMed ID: 22285250
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
    Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
    Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Embryonic striatal grafts restore neuronal activity of the globus pallidus in a rodent model of Huntington's disease.
    Nakao N; Ogura M; Nakai K; Itakura T
    Neuroscience; 1999 Jan; 88(2):469-77. PubMed ID: 10197767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protective effect of intrastriatal grafts in an experimental model of Huntington's disease. Behavioral and morphological correlation].
    Levivier M; Pearlman SH; Gash DM; Brotchi J
    Neurochirurgie; 1991; 37(3):148-59. PubMed ID: 1831884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes.
    Rossignol J; Boyer C; Lévèque X; Fink KD; Thinard R; Blanchard F; Dunbar GL; Lescaudron L
    Behav Brain Res; 2011 Mar; 217(2):369-78. PubMed ID: 21070819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficits induced by quinolinic acid lesion to the striatum in a position discrimination and reversal task are ameliorated by permanent and temporary lesion to the globus pallidus: a potential novel treatment in a rat model of Huntington's disease.
    Joel D; Ayalon L; Tarrasch R; Weiner I
    Mov Disord; 2003 Dec; 18(12):1499-507. PubMed ID: 14673887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.